UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022286
Receipt number R000025663
Scientific Title Investigating neurotransmitters by high-sensitivity proton MRS
Date of disclosure of the study information 2016/05/13
Last modified on 2021/12/08 15:43:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigating neurotransmitters by high-sensitivity proton MRS

Acronym

Investigating neurotransmitters by high-sensitivity proton MRS

Scientific Title

Investigating neurotransmitters by high-sensitivity proton MRS

Scientific Title:Acronym

Investigating neurotransmitters by high-sensitivity proton MRS

Region

Japan


Condition

Condition

brain diseases

Classification by specialty

Neurology Psychiatry Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the usefullness of MR sequences (SPECIAL and MEGA-PRESS) for evaluating neurotransmitters with healthy volunteers.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

A) Optimization of imaging parameters

B) evaluation of the sensitivity for measuring neurotransmitters by SPECIAL and MEGA-PRESS

Key secondary outcomes

1. Gender difference of brain metabolites
2. Regional distribution of brain metabolites
3. Association between brain and plasma metabolites


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

29 years-old >=

Gender

Male and Female

Key inclusion criteria

right handed

Key exclusion criteria

1. Persons who have brain diseases
2. Substance dependence
3. Persons who have serious complications or persons who had serious complications before which are not appropriate for this study based on the judgement of the researcher/doctor.
4. Persons who have a pacemaker or any metal in his body
5. Persons who have a tatoo
6. Persons who have serious claustrophobia
7. Pregnancy
8. Other persons who are determined by the researcher/doctor.

Target sample size

24


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuhei Takado

Organization

National Institutes for Quantum and Radiological Science and Technology

Division name

Department of Functional Brain Imaging Research

Zip code


Address

4-9-1 Anagawa, Inage-ku, Chiba

TEL

043-206-3425

Email

takado.yuhei@qst.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yuhei Takado

Organization

National Institutes for Quantum and Radiological Science and Technology

Division name

Department of Functional Brain Imaging Research

Zip code


Address

4-9-1 Anagawa, Inage-ku, Chiba

TEL

043-206-3425

Homepage URL


Email

takado.yuhei@qst.go.jp


Sponsor or person

Institute

National Institutes for Quantum and Radiological Science and Technology

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science & Technology in Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 05 Month 13 Day

Date of IRB

2016 Year 05 Month 10 Day

Anticipated trial start date

2016 Year 05 Month 13 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2018 Year 02 Month 28 Day


Other

Other related information

The sensitivity of the measurement of each pulse sequence will be observed.


Management information

Registered date

2016 Year 05 Month 12 Day

Last modified on

2021 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025663


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name